Adaptimmune Therapeutics plc
USD0.05
-0.00 (-3.00%)
CEO
Adrian G. Rawcliffe
IPO Date
2015-05-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$0.04
Prev. Close
$0.05
Day Low
$0.04
Day High
$0.06
52W Low
$0.02
52W High
$0.86
Market Cap
$0.08B
Volume
1.68M
| -1.4 |
| 31 Dec 2022 | FY | -370.5% | -609.5% | -202.1% | -50.3% | 0.28 | 3.96 | -1.4 |
| 31 Dec 2021 | FY | -1706.6% | -2571.0% | -76.8% | -33.7% | 0.12 | 6.64 | -3.7 |
| 31 Dec 2020 | FY | -2213.5% | -3286.8% | -38.1% | -28.8% | 0.07 | 10.19 | -5.9 |
| 31 Dec 2019 | FY | -8589.9% | -12225.0% | -110.9% | -75.6% | 0.21 | 3.51 | -0.9 |
| 31 Dec 2018 | FY | 100.0% | -160.5% | -38.7% | -34.5% | 0.55 | 9.46 | -5.9 |
| 31 Dec 2017 | FY | 100.0% | -185.4% | -34.6% | -24.9% | 0.61 | 3.10 | -8.4 |
| 31 Dec 2016 | FY | 100.0% | -504.1% | -43.1% | -30.5% | 0.00 | 4.94 | -4.0 |
| 30 Jun 2015 | FY | 100.0% | -201.4% | -8.3% | -7.2% | 0.00 | 11.03 | -30.4 |
| -0.3 |
| 31 Dec 2024 | Q4 | 100.0% | -2303.4% | -626.3% | -30.2% | 6.26 | 2.92 | -0.5 |
| 30 Sept 2024 | Q3 | 100.0% | -43.1% | -22.0% | -5.5% | 0.93 | 3.85 | -3.4 |
| 30 Jun 2024 | Q2 | 98.0% | 54.2% | 72.2% | 21.6% | 0.49 | 3.09 | 1.0 |
| 31 Mar 2024 | Q1 | 50.2% | -854.2% | -199.0% | -18.8% | 0.97 | 2.81 | -1.8 |
| 31 Dec 2023 | Q4 | -1133.8% | -20743.3% | -122.3% | -17.1% | 0.64 | 2.85 | -0.9 |
| 30 Sept 2023 | Q3 | 60.7% | -623.0% | -51.7% | -15.4% | 0.29 | 2.92 | -1.0 |
| 30 Jun 2023 | Q2 | 56.4% | -416.9% | -16.9% | -6.2% | 0.21 | 3.44 | -2.0 |
| 31 Mar 2023 | Q1 | 96.1% | 2.2% | 1.2% | 0.4% | 0.27 | 3.36 | 43.5 |